CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 73 filers reported holding CHEMOCENTRYX INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $718,000 | +1495.6% | 160,000 | +1500.0% | 0.69% | +1871.4% |
Q3 2014 | $45,000 | -61.5% | 10,000 | -50.0% | 0.04% | -58.3% |
Q2 2014 | $117,000 | -89.9% | 20,000 | -88.5% | 0.08% | -91.4% |
Q1 2014 | $1,156,000 | +14.1% | 174,297 | -0.4% | 0.97% | +18.8% |
Q4 2013 | $1,013,000 | – | 175,000 | – | 0.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |